OR4K13

Across TCGA pan-cancer cohorts, OR4K13 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR4K13 data layer compared with 10 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher OR4K13 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4K13 expression acts as an unfavorable survival marker.

KICH, KIRC, and LUSC are the cancer types where OR4K13 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
KIRC	OS	Median	All	0.057	0.881	<.001	12	view →
LUSC	OS	Median	III,IV	0.330	0.679	.012	7	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR4K13–KICH (DFS)

Open the KICH breakdown →